DeVinney Erick Wayne — SEC Form 4 filings

SEC reporting owner CIK 1595972. 13 Form 4 filings on record with FilingPulse; latest filed 2026-03-18.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-02-23 to 2026-03-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Axogen, Inc. (AXGN)Chief Innovation Officer137 legs · 45,564 sh · $1,098,66731

Form 4 filings — DeVinney Erick Wayne

FiledFormIssuerReported transactionsSource
2026-03-184Axogen, Inc. (AXGN)Option exercise (M): 6,363 @ $0 · Tax withholding (F): 2,870 @ $32.84 · Option exercise (M): 11,575 @ $0 · Sale (S): 5,221 @ $32.84 · Option exercise (M): 6,363 (derivative) @ $0 · Option exercise (M): 11,575 (derivative) @ $0EDGAR
2026-03-024Axogen, Inc. (AXGN)Grant/award (A): 33,780 @ $0 · Tax withholding (F): 10,702 @ $31.90 · Tax withholding (F): 11,276 @ $30.65 · Grant/award (A): 23,000 (derivative) @ $0EDGAR
2025-12-104Axogen, Inc. (AXGN)Sale (S): 19,517 @ $31.21EDGAR
2025-12-054Axogen, Inc. (AXGN)Grant/award (A): 40,000 @ $0EDGAR
2025-09-164Axogen, Inc. (AXGN)Grant/award (A): 2,500 @ $0 · Sale (S): 1,137 @ $16.29EDGAR
2025-03-264Axogen, Inc. (AXGN)Grant/award (A): 38,000 (derivative) @ $0EDGAR
2025-03-194Axogen, Inc. (AXGN)Option exercise (M): 2,950 @ $0 · Option exercise (M): 6,362 @ $0 · Option exercise (M): 23,150 @ $0 · Sale (S): 15,111 @ $17.50 · Option exercise (M): 2,950 (derivative) @ $0 · Option exercise (M): 6,362 (derivative) @ $0 · +1 moreEDGAR
2025-03-044Axogen, Inc. (AXGN)Option exercise (M): 24,799 @ $0 · Tax withholding (F): 8,296 @ $18.35EDGAR
2025-02-264Axogen, Inc. (AXGN)Grant/award (A): 2,500 @ $0 · Tax withholding (F): 972 @ $16.50EDGAR
2024-09-134Axogen, Inc. (AXGN)Grant/award (A): 2,500 @ $0EDGAR
2024-03-254Axogen, Inc. (AXGN)Option exercise (M): 3,000 @ $0 · Sale (S): 716 @ $7.68 · Option exercise (M): 2,950 @ $0 · Sale (S): 721 @ $7.68 · Option exercise (M): 12,725 @ $0 · Sale (S): 3,141 @ $7.68 · +3 moreEDGAR
2024-03-054Axogen, Inc. (AXGN)Grant/award (A): 50,000EDGAR
2024-02-234Axogen, Inc. (AXGN)Grant/award (A): 68,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1595972 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →